[
    [
        {
            "time": "",
            "original_text": "药企半年报：圣湘生物领跑抗疫股 康美药业等问题企业业绩下滑 盈利能力下降",
            "features": {
                "keywords": [
                    "药企",
                    "半年报",
                    "圣湘生物",
                    "抗疫股",
                    "康美药业",
                    "业绩下滑",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药企半年报：圣湘生物领跑抗疫股 康美药业等问题企业业绩下滑 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]